カテゴリ： 世界, 医療/バイオ, Market Monitor Global

重症鼻閉用点鼻薬のグローバル市場展望 2023年-2029年：メンソール入り重症鼻閉用点鼻薬、メンソール無し重症鼻閉用点鼻薬

■ 英語タイトル：Severe Congestion Nasal Spray Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23LY7970）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23LY7970
■ 発行日：2023年7月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医療機器＆消耗品
■ ページ数：118
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[重症鼻閉用点鼻薬のグローバル市場展望 2023年-2029年：メンソール入り重症鼻閉用点鼻薬、メンソール無し重症鼻閉用点鼻薬]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界の重症鼻閉用点鼻薬市場規模と予測を収録しています。・世界の重症鼻閉用点鼻薬市場：売上、2018年-2023年、2024年-2029年
・世界の重症鼻閉用点鼻薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の重症鼻閉用点鼻薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「メンソール入り重症鼻閉用点鼻薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

重症鼻閉用点鼻薬のグローバル主要企業は、Afrin、 Vicks、 Zicam、 Otrivin、 Allergan、 Beximco Pharmaceuticals、 Cipla、 Mylan N V、 Nephron Pharmaceuticals、 Sun Pharmaceutical Industries、 Hikma Pharmaceuticals、 Novartis、 Perrigo、 Catalent Pharma Solutions、 Teva Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、重症鼻閉用点鼻薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の重症鼻閉用点鼻薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の重症鼻閉用点鼻薬市場：タイプ別市場シェア、2022年
・メンソール入り重症鼻閉用点鼻薬、メンソール無し重症鼻閉用点鼻薬

世界の重症鼻閉用点鼻薬市場：用途別、2018年-2023年、2024年-2029年
世界の重症鼻閉用点鼻薬市場：用途別市場シェア、2022年
・病院、クリニック、その他

世界の重症鼻閉用点鼻薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の重症鼻閉用点鼻薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における重症鼻閉用点鼻薬のグローバル売上、2018年-2023年
・主要企業における重症鼻閉用点鼻薬のグローバル売上シェア、2022年
・主要企業における重症鼻閉用点鼻薬のグローバル販売量、2018年-2023年
・主要企業における重症鼻閉用点鼻薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Afrin、 Vicks、 Zicam、 Otrivin、 Allergan、 Beximco Pharmaceuticals、 Cipla、 Mylan N V、 Nephron Pharmaceuticals、 Sun Pharmaceutical Industries、 Hikma Pharmaceuticals、 Novartis、 Perrigo、 Catalent Pharma Solutions、 Teva Pharmaceutical Industries

*************************************************************

・調査・分析レポートの概要
重症鼻閉用点鼻薬市場の定義
市場セグメント
世界の重症鼻閉用点鼻薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の重症鼻閉用点鼻薬市場規模
世界の重症鼻閉用点鼻薬市場規模：2022年 VS 2029年
世界の重症鼻閉用点鼻薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの重症鼻閉用点鼻薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の重症鼻閉用点鼻薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：メンソール入り重症鼻閉用点鼻薬、メンソール無し重症鼻閉用点鼻薬
重症鼻閉用点鼻薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、クリニック、その他
重症鼻閉用点鼻薬の用途別グローバル売上・予測

・地域別市場分析
地域別重症鼻閉用点鼻薬市場規模 2022年と2029年
地域別重症鼻閉用点鼻薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Afrin、 Vicks、 Zicam、 Otrivin、 Allergan、 Beximco Pharmaceuticals、 Cipla、 Mylan N V、 Nephron Pharmaceuticals、 Sun Pharmaceutical Industries、 Hikma Pharmaceuticals、 Novartis、 Perrigo、 Catalent Pharma Solutions、 Teva Pharmaceutical Industries
...

Severe congestion nasal spray can be used for temporary relief of nasal congestion due to colds, hay fever, upper respiratory tract allergies, sinus congestion and pressure.
This report aims to provide a comprehensive presentation of the global market for Severe Congestion Nasal Spray, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Severe Congestion Nasal Spray. This report contains market size and forecasts of Severe Congestion Nasal Spray in global, including the following market information:
Global Severe Congestion Nasal Spray Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Severe Congestion Nasal Spray Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Severe Congestion Nasal Spray companies in 2022 (%)
The global Severe Congestion Nasal Spray market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Severe Congestion Nasal Spray with Menthol Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Severe Congestion Nasal Spray include Afrin, Vicks, Zicam, Otrivin, Allergan, Beximco Pharmaceuticals, Cipla, Mylan N V and Nephron Pharmaceuticals, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Severe Congestion Nasal Spray manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Severe Congestion Nasal Spray Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Severe Congestion Nasal Spray Market Segment Percentages, by Type, 2022 (%)
Severe Congestion Nasal Spray with Menthol
Severe Congestion Nasal Spray without Menthol
Global Severe Congestion Nasal Spray Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Severe Congestion Nasal Spray Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Others
Global Severe Congestion Nasal Spray Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Severe Congestion Nasal Spray Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Severe Congestion Nasal Spray revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Severe Congestion Nasal Spray revenues share in global market, 2022 (%)
Key companies Severe Congestion Nasal Spray sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Severe Congestion Nasal Spray sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Afrin
Vicks
Zicam
Otrivin
Allergan
Beximco Pharmaceuticals
Cipla
Mylan N V
Nephron Pharmaceuticals
Sun Pharmaceutical Industries
Hikma Pharmaceuticals
Novartis
Perrigo
Catalent Pharma Solutions
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Severe Congestion Nasal Spray, market overview.
Chapter 2: Global Severe Congestion Nasal Spray market size in revenue and volume.
Chapter 3: Detailed analysis of Severe Congestion Nasal Spray manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Severe Congestion Nasal Spray in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Severe Congestion Nasal Spray capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Severe Congestion Nasal Spray Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Severe Congestion Nasal Spray Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Severe Congestion Nasal Spray Overall Market Size
2.1 Global Severe Congestion Nasal Spray Market Size: 2022 VS 2029
2.2 Global Severe Congestion Nasal Spray Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Severe Congestion Nasal Spray Sales: 2018-2029
3 Company Landscape
3.1 Top Severe Congestion Nasal Spray Players in Global Market
3.2 Top Global Severe Congestion Nasal Spray Companies Ranked by Revenue
3.3 Global Severe Congestion Nasal Spray Revenue by Companies
3.4 Global Severe Congestion Nasal Spray Sales by Companies
3.5 Global Severe Congestion Nasal Spray Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Severe Congestion Nasal Spray Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Severe Congestion Nasal Spray Product Type
3.8 Tier 1, Tier 2 and Tier 3 Severe Congestion Nasal Spray Players in Global Market
3.8.1 List of Global Tier 1 Severe Congestion Nasal Spray Companies
3.8.2 List of Global Tier 2 and Tier 3 Severe Congestion Nasal Spray Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Severe Congestion Nasal Spray Market Size Markets, 2022 & 2029
4.1.2 Severe Congestion Nasal Spray with Menthol
4.1.3 Severe Congestion Nasal Spray without Menthol
4.2 By Type – Global Severe Congestion Nasal Spray Revenue & Forecasts
4.2.1 By Type – Global Severe Congestion Nasal Spray Revenue, 2018-2023
4.2.2 By Type – Global Severe Congestion Nasal Spray Revenue, 2024-2029
4.2.3 By Type – Global Severe Congestion Nasal Spray Revenue Market Share, 2018-2029
4.3 By Type – Global Severe Congestion Nasal Spray Sales & Forecasts
4.3.1 By Type – Global Severe Congestion Nasal Spray Sales, 2018-2023
4.3.2 By Type – Global Severe Congestion Nasal Spray Sales, 2024-2029
4.3.3 By Type – Global Severe Congestion Nasal Spray Sales Market Share, 2018-2029
4.4 By Type – Global Severe Congestion Nasal Spray Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Severe Congestion Nasal Spray Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application – Global Severe Congestion Nasal Spray Revenue & Forecasts
5.2.1 By Application – Global Severe Congestion Nasal Spray Revenue, 2018-2023
5.2.2 By Application – Global Severe Congestion Nasal Spray Revenue, 2024-2029
5.2.3 By Application – Global Severe Congestion Nasal Spray Revenue Market Share, 2018-2029
5.3 By Application – Global Severe Congestion Nasal Spray Sales & Forecasts
5.3.1 By Application – Global Severe Congestion Nasal Spray Sales, 2018-2023
5.3.2 By Application – Global Severe Congestion Nasal Spray Sales, 2024-2029
5.3.3 By Application – Global Severe Congestion Nasal Spray Sales Market Share, 2018-2029
5.4 By Application – Global Severe Congestion Nasal Spray Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Severe Congestion Nasal Spray Market Size, 2022 & 2029
6.2 By Region – Global Severe Congestion Nasal Spray Revenue & Forecasts
6.2.1 By Region – Global Severe Congestion Nasal Spray Revenue, 2018-2023
6.2.2 By Region – Global Severe Congestion Nasal Spray Revenue, 2024-2029
6.2.3 By Region – Global Severe Congestion Nasal Spray Revenue Market Share, 2018-2029
6.3 By Region – Global Severe Congestion Nasal Spray Sales & Forecasts
6.3.1 By Region – Global Severe Congestion Nasal Spray Sales, 2018-2023
6.3.2 By Region – Global Severe Congestion Nasal Spray Sales, 2024-2029
6.3.3 By Region – Global Severe Congestion Nasal Spray Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Severe Congestion Nasal Spray Revenue, 2018-2029
6.4.2 By Country – North America Severe Congestion Nasal Spray Sales, 2018-2029
6.4.3 US Severe Congestion Nasal Spray Market Size, 2018-2029
6.4.4 Canada Severe Congestion Nasal Spray Market Size, 2018-2029
6.4.5 Mexico Severe Congestion Nasal Spray Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Severe Congestion Nasal Spray Revenue, 2018-2029
6.5.2 By Country – Europe Severe Congestion Nasal Spray Sales, 2018-2029
6.5.3 Germany Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.4 France Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.5 U.K. Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.6 Italy Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.7 Russia Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.8 Nordic Countries Severe Congestion Nasal Spray Market Size, 2018-2029
6.5.9 Benelux Severe Congestion Nasal Spray Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Severe Congestion Nasal Spray Revenue, 2018-2029
6.6.2 By Region – Asia Severe Congestion Nasal Spray Sales, 2018-2029
6.6.3 China Severe Congestion Nasal Spray Market Size, 2018-2029
6.6.4 Japan Severe Congestion Nasal Spray Market Size, 2018-2029
6.6.5 South Korea Severe Congestion Nasal Spray Market Size, 2018-2029
6.6.6 Southeast Asia Severe Congestion Nasal Spray Market Size, 2018-2029
6.6.7 India Severe Congestion Nasal Spray Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Severe Congestion Nasal Spray Revenue, 2018-2029
6.7.2 By Country – South America Severe Congestion Nasal Spray Sales, 2018-2029
6.7.3 Brazil Severe Congestion Nasal Spray Market Size, 2018-2029
6.7.4 Argentina Severe Congestion Nasal Spray Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Severe Congestion Nasal Spray Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Severe Congestion Nasal Spray Sales, 2018-2029
6.8.3 Turkey Severe Congestion Nasal Spray Market Size, 2018-2029
6.8.4 Israel Severe Congestion Nasal Spray Market Size, 2018-2029
6.8.5 Saudi Arabia Severe Congestion Nasal Spray Market Size, 2018-2029
6.8.6 UAE Severe Congestion Nasal Spray Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Afrin
7.1.1 Afrin Company Summary
7.1.2 Afrin Business Overview
7.1.3 Afrin Severe Congestion Nasal Spray Major Product Offerings
7.1.4 Afrin Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.1.5 Afrin Key News & Latest Developments
7.2 Vicks
7.2.1 Vicks Company Summary
7.2.2 Vicks Business Overview
7.2.3 Vicks Severe Congestion Nasal Spray Major Product Offerings
7.2.4 Vicks Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.2.5 Vicks Key News & Latest Developments
7.3 Zicam
7.3.1 Zicam Company Summary
7.3.2 Zicam Business Overview
7.3.3 Zicam Severe Congestion Nasal Spray Major Product Offerings
7.3.4 Zicam Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.3.5 Zicam Key News & Latest Developments
7.4 Otrivin
7.4.1 Otrivin Company Summary
7.4.2 Otrivin Business Overview
7.4.3 Otrivin Severe Congestion Nasal Spray Major Product Offerings
7.4.4 Otrivin Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.4.5 Otrivin Key News & Latest Developments
7.5 Allergan
7.5.1 Allergan Company Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Severe Congestion Nasal Spray Major Product Offerings
7.5.4 Allergan Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.5.5 Allergan Key News & Latest Developments
7.6 Beximco Pharmaceuticals
7.6.1 Beximco Pharmaceuticals Company Summary
7.6.2 Beximco Pharmaceuticals Business Overview
7.6.3 Beximco Pharmaceuticals Severe Congestion Nasal Spray Major Product Offerings
7.6.4 Beximco Pharmaceuticals Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.6.5 Beximco Pharmaceuticals Key News & Latest Developments
7.7 Cipla
7.7.1 Cipla Company Summary
7.7.2 Cipla Business Overview
7.7.3 Cipla Severe Congestion Nasal Spray Major Product Offerings
7.7.4 Cipla Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.7.5 Cipla Key News & Latest Developments
7.8 Mylan N V
7.8.1 Mylan N V Company Summary
7.8.2 Mylan N V Business Overview
7.8.3 Mylan N V Severe Congestion Nasal Spray Major Product Offerings
7.8.4 Mylan N V Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.8.5 Mylan N V Key News & Latest Developments
7.9 Nephron Pharmaceuticals
7.9.1 Nephron Pharmaceuticals Company Summary
7.9.2 Nephron Pharmaceuticals Business Overview
7.9.3 Nephron Pharmaceuticals Severe Congestion Nasal Spray Major Product Offerings
7.9.4 Nephron Pharmaceuticals Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.9.5 Nephron Pharmaceuticals Key News & Latest Developments
7.10 Sun Pharmaceutical Industries
7.10.1 Sun Pharmaceutical Industries Company Summary
7.10.2 Sun Pharmaceutical Industries Business Overview
7.10.3 Sun Pharmaceutical Industries Severe Congestion Nasal Spray Major Product Offerings
7.10.4 Sun Pharmaceutical Industries Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.10.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.11 Hikma Pharmaceuticals
7.11.1 Hikma Pharmaceuticals Company Summary
7.11.2 Hikma Pharmaceuticals Severe Congestion Nasal Spray Business Overview
7.11.3 Hikma Pharmaceuticals Severe Congestion Nasal Spray Major Product Offerings
7.11.4 Hikma Pharmaceuticals Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.11.5 Hikma Pharmaceuticals Key News & Latest Developments
7.12 Novartis
7.12.1 Novartis Company Summary
7.12.2 Novartis Severe Congestion Nasal Spray Business Overview
7.12.3 Novartis Severe Congestion Nasal Spray Major Product Offerings
7.12.4 Novartis Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.12.5 Novartis Key News & Latest Developments
7.13 Perrigo
7.13.1 Perrigo Company Summary
7.13.2 Perrigo Severe Congestion Nasal Spray Business Overview
7.13.3 Perrigo Severe Congestion Nasal Spray Major Product Offerings
7.13.4 Perrigo Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.13.5 Perrigo Key News & Latest Developments
7.14 Catalent Pharma Solutions
7.14.1 Catalent Pharma Solutions Company Summary
7.14.2 Catalent Pharma Solutions Business Overview
7.14.3 Catalent Pharma Solutions Severe Congestion Nasal Spray Major Product Offerings
7.14.4 Catalent Pharma Solutions Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.14.5 Catalent Pharma Solutions Key News & Latest Developments
7.15 Teva Pharmaceutical Industries
7.15.1 Teva Pharmaceutical Industries Company Summary
7.15.2 Teva Pharmaceutical Industries Business Overview
7.15.3 Teva Pharmaceutical Industries Severe Congestion Nasal Spray Major Product Offerings
7.15.4 Teva Pharmaceutical Industries Severe Congestion Nasal Spray Sales and Revenue in Global (2018-2023)
7.15.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Severe Congestion Nasal Spray Production Capacity, Analysis
8.1 Global Severe Congestion Nasal Spray Production Capacity, 2018-2029
8.2 Severe Congestion Nasal Spray Production Capacity of Key Manufacturers in Global Market
8.3 Global Severe Congestion Nasal Spray Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Severe Congestion Nasal Spray Supply Chain Analysis
10.1 Severe Congestion Nasal Spray Industry Value Chain
10.2 Severe Congestion Nasal Spray Upstream Market
10.3 Severe Congestion Nasal Spray Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Severe Congestion Nasal Spray Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 吸入式鼻腔インフルエンザワクチンのグローバル市場展望 2023年-2029年：弱毒生インフルエンザワクチン、分割インフルエンザワクチン
  • 充血除去剤点鼻薬の世界市場インサイト・予測（～2028年）
  • いびき防止用外鼻拡張器のグローバル市場展望 2023年-2029年：大人向けいびき防止用外鼻拡張器、子供向けいびき防止用外鼻拡張器
  • 鼻スワブ迅速サンプリングラインのグローバル市場展望 2023年-2029年：ローフロー鼻サンプリングライン、ハイフロー鼻サンプリングライン
  • 高流量鼻酸素療法システムのグローバル市場展望 2023年-2029年：自動酸素調整、手動酸素調整
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23LY7970 )"重症鼻閉用点鼻薬のグローバル市場展望 2023年-2029年：メンソール入り重症鼻閉用点鼻薬、メンソール無し重症鼻閉用点鼻薬" (英文：Severe Congestion Nasal Spray Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。